AZTR Latest Press Releases

-- October 29, 2026 --

Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors PRNewswire 8:30 AM

-- October 26, 2026 --

Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin PRNewswire 8:46 AM

-- October 16, 2026 --

Azitra, Inc. Announces Reverse Stock Split PRNewswire 8:00 AM

-- October 1, 2026 --

Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance PRNewswire 8:01 AM

-- September 8, 2026 --

Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 8:00 AM

-- August 21, 2026 --

Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards PRNewswire 8:00 AM

-- August 12, 2026 --

Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates PRNewswire 5:00 PM

-- July 15, 2026 --

/C O R R E C T I O N -- Azitra, Inc./ PRNewswire 11:34 AM

Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity PRNewswire 10:11 AM

-- June 17, 2026 --

Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond PRNewswire 8:01 AM

-- June 16, 2026 --

Azitra, Inc. to Present at 2026 BIO International Convention PRNewswire 5:29 PM

-- June 4, 2026 --

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting PRNewswire 4:05 PM

Market Data Delayed 15 Minutes